Results 51 to 60 of about 2,781,392 (308)

Genetic variability, heritability and genetic advance in soybean [Glycine max (L.) Merrill] [PDF]

Electronic Journal of Plant Breeding, 2014
Sixty one genotypes of soybean were evaluated to determine genetic variability, heritability and genetic advance for 15 contributing characters. The analysis of variance revealed significant variations for all characters. The estimates of phenotypic (PCV)
V. V. Baraskar, V. H. Kachhadia, J. H. VachhanI*, H. R. Barad, M. B. Patel and M. S. Darwankar
doaj  

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine, Hallie Coltin, Sylvia Cheng, Lucie Lafay‐Cousin, Vanan Issai Magimairajan, Craig Erker, Stéphanie Vairy, Lynette Bowes, Adam Fleming, Donna Johnston, Sarah McKillop, Roona Sinha, Julie Bennett, Christina Coleman, Laura Wheaton, Shayna Zelcer, Samuele Renzi, Thai Hoa Tran   +17 more
wiley   +1 more source

Studies on genetic variability, heritability and genetic advance for quantitative traits and nutritional traits in rice (Oryza sativa L.)

Electronic Journal of Plant Breeding, 2023
Fifty selected rice genotypes including two checks were evaluated during Kharif, 2022-23 for genetic variability, heritability and genetic advance as per cent of mean for 16 yield and its attributing traits along with six nutritional parameters in ...
Sourav Paramanik1, M. Subba Rao1*, Rashmi K.1, Koustava Kumar Panda2 and Aninda Chakraborty1
doaj   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani, Rachel K. Peterson, Avani D. Rao, Laurie J. McKenzie, Ahmed Magdy Elmotayam, Leslie Chang, Michael Roth, Susan L. McGovern   +7 more
wiley   +1 more source

The Squamish Advance: March 15, 1951 [PDF]

, 1951
[description] Vol. 1. No. 35 "Thorne, Mr. I" written in pencil at top left of front page. Includes mention of Irwin Thorne in front-page story "Local Hunters Bag Fourteen 'Cats". Pencil dashes can be seen above the story title. The Squamish Advance was a

core  

Estimation of genetic variability in blackgram [Vigna mungo(L.) Hepper]

Electronic Journal of Plant Breeding, 2021
An investigation was carried out during kharif, 2018 in Randomized Block Design to estimate the variability parameters in blackgram using thirty five genotypes including two checks viz., Pratap Urd-1 and Pant Urd-31.
Rajwanti Saran* and P. P. Sharma
doaj   +1 more source

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben, Marisa H. Huisman, Martha A. Grootenhuis, Femke K. Aarsen, Marita Partanen   +4 more
wiley   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk, Sebastian Michaelis, Michaela Döring, Thomas Eichholz, Ursula Holzer, Martin Ebinger, Tim Flaadt, Rupert Handgretinger, Peter Lang, Jan Frederic Weller, Markus Mezger   +10 more
wiley   +1 more source

Markkinointisuunnitelma Advance U [PDF]

, 2021
Opinnäytetyö toteutettiin toimeksiantona Advance U:lle, joka on tekijän oma toiminimiyritys. Advance U on fyysiseen valmennukseen erikoistunut valmennuspalvelu, jonka tavoitteena on tuotetarjooman laajentamisen myötä kasvattaa liiketoimintaa, joka ...
Mäkipernaa, Heikki
core  

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source